Medicus Pharma (MDCX) Common Equity (2023 - 2025)

Medicus Pharma (MDCX) has reported Common Equity for 3 consecutive years, with -$67554.0 the latest figure, recorded in Q4 2025.

• Common Equity for Q4 2025 came in at -$67554.0, down 102.16% year-over-year; the trailing twelve-month figure through Dec 2025 was -$67554.0 (down 102.16% YoY), and the FY2025 annual result was -$67554.0, down 102.16% from the prior year.
• Common Equity was -$67554.0 for Q4 2025 at Medicus Pharma, up from -$910126.0 in the prior quarter.
• Over five years, Common Equity peaked at $7.1 million in Q2 2024 and troughed at -$910126.0 in Q3 2025.
• Average Common Equity over 3 years is $2.2 million, with a median of $2.1 million recorded in 2025.
• The widest YoY moves for Common Equity: up 483.52% in 2025, down 118.98% in 2025.
• Over 3 years, Common Equity stood at $1.1 million in 2023, then jumped by 182.04% to $3.1 million in 2024, then plunged by 102.16% to -$67554.0 in 2025.
• Per Business Quant data, the three most recent Common Equity figures were -$67554.0 in Q4 2025, -$910126.0 in Q3 2025, and $3.2 million in Q2 2025.